×
For best experience we recommend to activate Javascript in your browser.
NMT2 antibody
The Rabbit Polyclonal anti-NMT2 antibody has been validated for WB, IHC, IF and IC. It is suitable to detect NMT2 in samples from Human, Mouse and Rat.
Quick Overview for NMT2 antibody (ABIN7310350)
Target
See all NMT2 Antibodies
NMT2
(N-Myristoyltransferase 2 (NMT2))
Reactivity
All reactivities for NMT2 antibodies
Human, Mouse, Rat
Host
All hosts for NMT2 antibodies
Rabbit
Clonality
All clonalities for NMT2 antibodies
Polyclonal
Conjugate
All conjugates for NMT2 antibodies
This NMT2 antibody is un-conjugated
Application
All applications for NMT2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunochromatography (IC)
Product Details anti-NMT2 Antibody
(hide)
Specificity
Recognizes endogenous levels of NMT2 protein.
Characteristics
Rabbit polyclonal antibody to NMT2
Purification
The antibody was purified by immunogen affinity chromatography.
Immunogen
Recombinant full length protein of human NMT2
Alternatives
(show)
Application Details
(hide)
Application Notes
WB (1:500 - 1:2000), IH (1:50 - 1:200), IF/IC (1:50 - 1:200)
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
Expiry Date
12 months
Target Details for NMT2
(hide)
Target
NMT2
(N-Myristoyltransferase 2 (NMT2))
Alternative Name
NMT2
Background
Glycylpeptide N-tetradecanoyltransferase 2, Myristoyl-CoA:protein N-myristoyltransferase 2, NMT 2, Peptide N-myristoyltransferase 2, Type II N-myristoyltransferase
Gene ID
9397, 18108
UniProt
O60551 , O70311
Pathways
Regulation of G-Protein Coupled Receptor Protein Signaling
Recently viewed
(hide)
Chat with us , powered by LiveChat